FDA staff supports wider Selzentry use

Pfizer's (PFE) HIV drug Selzentry appears to be safe for wider use in patients with the disease who have not begun taking any medications yet, FDA staff said in a document released today. Report

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.